Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy.

Fuwu Zhang,Guizhi Zhu,Orit Jacobson,Yi Liu,Kai Chen,Guocan Yu,Qianqian Ni,Jing Fan,Zhen Yang,Frederick Xu,Xiao Fu,Zhe Wang,Ying Ma,Gang Niu,Xiaobin Zhao,Xiaoyuan Chen

DOI: https://doi.org/10.1021/acsnano.7b03003

IF: 17.1

2017-01-01

ACS Nano

Abstract:We report a camptothecin (CPT) prodrug that was well formulated in solution and rapidly transformed into long-circulating nanocomplexes in vivo for highly efficient drug delivery and effective cancer therapy. Specifically, using a redox-responsive disulfide linker, CPT was conjugated with an albumin-binding Evans Blue (EB) derivative; the resulting amphiphilic CPT-ss-EB prodrug self-assembled into nanostructures in aqueous solution, thus conferring high solubility and stability. By binding of CPT-ss-EB to endogenous albumin, the 80-nm CPT-ss-EB nanoparticles rapidly transformed into 7-nm albumin/prodrug nanocomplexes. CPT-ss-EB was efficient at intracellular delivery into cancer cells, released intact CPT in a redox-responsive manner, and exhibited cytotoxicity as potent as CPT. In mice, the albumin/CPT-ss-EB nanocomplex exhibited remarkably long blood circulation (130-fold greater than CPT) and efficient tumor accumulation (30-fold of CPT), which consequently contributed to excellent therapeutic efficacy. Overall, this novel strategy of transformative nanomedicine is promising for efficient drug delivery.